| ABBOTT LABORATORIES |
| USA |
| Gesundheit |
| US0028241000 / 850103 |
| ABL (Frankfurt) / ABT (NYSE) |
| FRA:ABL, ETR:ABL, ABL:GR, NYSE:ABT |
| S&P500 |
| https://www.abbott.com/ |
|
Abbott Laboratories is a global healthcare company that develops, manufactures, and markets a broad range of medical products and solutions. Abbott Laboratories operates across four core segments: established pharmaceutical products, diagnostic produ..
>Volltext.. |
| 161165.68 Mio. EUR |
| 185342.69 Mio. EUR |
| 41448.86 Mio. EUR |
| 9881.53 Mio. EUR |
| 4809.08 Mio. EUR |
| 2.76 EUR |
| 29012.87 Mio. EUR |
| 4541.27 Mio. EUR |
| 8812.94 Mio. EUR |
| 0.31 |
| 11.46% |
| -59.99% |
| 1.63 EUR |
| 2.37% |
| 2.41% |
| 15.07.26 - 0.550431€ 15.04.26 - 0.53442895€ >weitere anzeigen... |
| - |
| ABBOTT LABORATORIES, ABBOTT LABS, ABBOTT LAB, (ABT), ABT |
| 18.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|